Pamela Noeldner

762 total citations
10 papers, 595 citations indexed

About

Pamela Noeldner is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Developmental Neuroscience. According to data from OpenAlex, Pamela Noeldner has authored 10 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Endocrine and Autonomic Systems and 3 papers in Developmental Neuroscience. Recurrent topics in Pamela Noeldner's work include Regulation of Appetite and Obesity (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Pamela Noeldner is often cited by papers focused on Regulation of Appetite and Obesity (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Pamela Noeldner collaborates with scholars based in United States, Italy and Australia. Pamela Noeldner's co-authors include Anthony R. Means, Kristin A. Anderson, Fumin Lin, Thomas J. Ribar, Michelle Green, Bruce E. Kemp, Michael J. Muehlbauer, Lee A. Witters, Luigi Racioppi and Brian E. Wadzinski and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Cell Metabolism.

In The Last Decade

Pamela Noeldner

10 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela Noeldner United States 7 344 133 128 103 74 10 595
Sookhee Bang United States 11 280 0.8× 190 1.4× 68 0.5× 68 0.7× 95 1.3× 14 619
Patricia Rouet‐Benzineb France 13 368 1.1× 94 0.7× 69 0.5× 239 2.3× 89 1.2× 23 912
Ernesto Caballero‐Garrido Spain 8 243 0.7× 119 0.9× 90 0.7× 115 1.1× 48 0.6× 10 650
Estelle Woldt France 7 339 1.0× 287 2.2× 90 0.7× 225 2.2× 50 0.7× 9 845
I. Moroo Japan 9 259 0.8× 126 0.9× 103 0.8× 46 0.4× 145 2.0× 20 623
Yaiza Esteban Spain 10 442 1.3× 283 2.1× 135 1.1× 195 1.9× 37 0.5× 20 849
Xiang Gu China 16 353 1.0× 122 0.9× 50 0.4× 80 0.8× 94 1.3× 43 714
M. Wakui Japan 14 500 1.5× 165 1.2× 170 1.3× 54 0.5× 222 3.0× 37 831
Judith A. Herlein United States 12 248 0.7× 156 1.2× 75 0.6× 29 0.3× 56 0.8× 13 584
Karl Dreja Sweden 12 622 1.8× 240 1.8× 131 1.0× 39 0.4× 193 2.6× 16 1.0k

Countries citing papers authored by Pamela Noeldner

Since Specialization
Citations

This map shows the geographic impact of Pamela Noeldner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Noeldner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Noeldner more than expected).

Fields of papers citing papers by Pamela Noeldner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Noeldner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Noeldner. The network helps show where Pamela Noeldner may publish in the future.

Co-authorship network of co-authors of Pamela Noeldner

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Noeldner. A scholar is included among the top collaborators of Pamela Noeldner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Noeldner. Pamela Noeldner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Scotland, Paula, et al.. (2017). Gene products promoting remyelination are up-regulated in a cell therapy product manufactured from banked human cord blood. Cytotherapy. 19(6). 771–782. 3 indexed citations
2.
Scotland, Paula, Pamela Noeldner, Tracy Gentry, et al.. (2016). A cord blood monocyte–derived cell therapy product accelerates brain remyelination. JCI Insight. 1(13). e86667–e86667. 23 indexed citations
5.
Racioppi, Luigi, et al.. (2012). Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 Regulates Macrophage-Mediated Inflammatory Responses (172.35). The Journal of Immunology. 188(1_Supplement). 172.35–172.35. 3 indexed citations
6.
Racioppi, Luigi, et al.. (2012). Calcium/Calmodulin-dependent Protein Kinase Kinase 2 Regulates Macrophage-mediated Inflammatory Responses. Journal of Biological Chemistry. 287(14). 11579–11591. 93 indexed citations
7.
Anderson, Kristin A., Thomas J. Ribar, Fumin Lin, et al.. (2008). Hypothalamic CaMKK2 Contributes to the Regulation of Energy Balance. Cell Metabolism. 7(5). 377–388. 300 indexed citations
8.
Anderson, Kristin A., et al.. (2005). The Autonomous Activity of Calcium/Calmodulin-dependent Protein Kinase IV Is Required for Its Role in Transcription. Journal of Biological Chemistry. 280(21). 20530–20538. 45 indexed citations
9.
Anderson, Kristin A., Pamela Noeldner, Kelie Reece, Brian E. Wadzinski, & Anthony R. Means. (2004). Regulation and Function of the Calcium/Calmodulin-dependent Protein Kinase IV/Protein Serine/Threonine Phosphatase 2A Signaling Complex. Journal of Biological Chemistry. 279(30). 31708–31716. 52 indexed citations
10.
Lemrow, Shannon M., Kristin A. Anderson, James D. Joseph, et al.. (2004). Catalytic Activity Is Required for Calcium/Calmodulin-dependent Protein Kinase IV to Enter the Nucleus. Journal of Biological Chemistry. 279(12). 11664–11671. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026